How much a stock's price changes over time is important for most investors, since price performance can both impact your investment portfolio and help you compare investment results across sectors and industries.FOMO, or the fear of missing out, also plays a role in investing, particularly with tech giants and popular consumer-facing stocks.What if you'd invested in Molina (MOH) ten years ago? It may not have been easy to hold on to MOH for all that time, but if you did, how much would your investment be worth today?Molina's Business In-DepthWith that in mind, let's take a look at Molina's main business drivers. Founded in 1980 and headquartered in Long Beach, CA, Molina Healthcare Inc. is a multi-state managed care organization participating exclusively in government-sponsored healthcare programs such as the Medicaid program and the State Children's Health Insurance Program (SCHIP), catering to low-income persons. It is a FORTUNE 500 company.The company provides managed healthcare services under the Medicaid and Medicare programs, and through the state insurance marketplaces (the Marketplace). Molina Healthcare expects its 2022 business to witness reduced impacts from COVID. Strong Medicare and Medicaid performance will buoy results.Molina Healthcare was formerly known as American Family Care Inc. until it changed its name in Mar 2000. The company currently operates in two segments: Health Plans and Other. The company manages most of its operations through the Health Plans segment.The Other segment mainly includes the results of the Pathways behavioral health unit, which Molina sold in the fourth quarter of 2018 apart from other corporate amounts not allocated to the segment.As of Dec 31, 2021, the company served around 5.2 million members through its locally-operated health plans across several markets, indicating a 29% year-over-year increase. This is reflective of an improving business scenario.The health plans are locally operated by wholly owned subsidiaries of Molina, each of which is licensed as a health maintenance organization, or HMO. Molina Healthcare derives revenues primarily from premiums paid to its health plans by the relevant state Medicaid authority. The premium revenues are jointly financed by the federal government and the states.The company also derives revenues from the federal Centers for Medicare and Medicaid Services (CMS) in connection with its Medicare services.Bottom LineWhile anyone can invest, building a lucrative investment portfolio takes research, patience, and a little bit of risk. If you had invested in Molina ten years ago, you're probably feeling pretty good about your investment today.A $1000 investment made in August 2012 would be worth $13,982.04, or a gain of 1,298.20%, as of August 3, 2022, according to our calculations. This return excludes dividends but includes price appreciation.The S&P 500 rose 199.72% and the price of gold increased 6.44% over the same time frame in comparison.Going forward, analysts are expecting more upside for MOH. Molina Healthcare is poised for growth on the back of its developmental strategies, improving top line and margin recovery. It began an enterprise-wide restructuring program to streamline structure to improve operational efficiency. Its upbeat 2022 guidance instils investors’ confidence. Robust performing Medicare and Medicaid businesses on contract wins and strategic initiatives will buoy results. Its bottom line keeps growing from the profitability improvement plan. It reported strong Q2 results on the back of rise in premiums. Although shares of the company have underperformed the industry in a year, we expect it to move forward in the coming days. Its balance sheet strength is impressive. However, its stretched valuation is worrisome. A high MCR ratio indicates a smaller amount of premium will be left over after paying insurance claims. The stock is up 17.38% over the past four weeks, and no earnings estimate has gone lower in the past two months, compared to 3 higher, for fiscal 2022. The consensus estimate has moved up as well. Zacks Names "Single Best Pick to Double" From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all. It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time. This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.Free: See Our Top Stock and 4 Runners Up >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Molina Healthcare, Inc (MOH): Free Stock Analysis Report To read this article on Zacks.com click here. Zacks Investment Research